CLAUS VON SCHORN: Open Payments
NPI 1982676417 · HARTSDALE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,854 in 26 payments from 7 companies in 2025. Trend: 2023 $1,733 · 2024 $1,225 · 2025 $1,854
Food & beverage: $1,854
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $568 |
| Janssen Pharmaceuticals, Inc | 4 | $472 |
| Otsuka America Pharmaceutical, Inc. | 7 | $291 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $179 |
| Luye Pharma (USA) Ltd. | 2 | $150 |
| ABBVIE INC. | 1 | $125 |
| Lundbeck LLC | 3 | $69 |
Products named: COBENFY, INVEGA SUSTENNA, ABILIFY MAINTENA, CAPLYTA, ERZOFRI EXTENDED-RELEASE, VRAYLAR, REXULTI.
Industry payments across NY — which companies pay providers there.
